Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Dörr

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|June 14, 2016
Haemopoietic stem-cell transplantation for multiple sclerosis: what next?Jan Dörr
Current Treatment Options in Neurology|April 28, 2015
The transition from first-line to second-line therapy in multiple sclerosisJan Dörr, Friedemann Paul
Drug Design, Development and Therapy|November 2, 2016
Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerationsJan Dörr, Karl Baum
Degenerative Neurological and Neuromuscular Disease|July 17, 2020
Optimal management of multiple sclerosis during pregnancy: current perspectivesNadja Borisow, Friedemann Paul, Jan Dörr
The EPMA Journal|January 30, 2013
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?Jan Dörr, Andrea Döring, Friedemann Paul
Trials|February 10, 2012
Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trialJan Dörr, Stephanie Ohlraun, Horst Skarabis, et al.
Journal of Alzheimer'S Disease : JAD|March 26, 2014
Update on Susac syndrome: new insights in brain and retinal imaging and treatment optionsJan Dörr, Marius Ringelstein, Thomas Duning, et al.
The EPMA Journal|June 29, 2012
Exercise in multiple sclerosis -- an integral component of disease managementAndrea Döring, Caspar F Pfueller, Friedemann Paul, et al.
Journal of Neuroimmunology|January 5, 2002
Induction of TRAIL-mediated glioma cell death by human T cellsJan Dörr, Sonia Waiczies, Uwe Wendling, et al.
Degenerative Neurological and Neuromuscular Disease|July 17, 2020
Optical coherence tomography for retinal imaging in multiple sclerosisHanna Zimmermann, Timm Oberwahrenbrock, Alexander U Brandt, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|June 14, 2016
Haemopoietic stem-cell transplantation for multiple sclerosis: what next?Jan Dörr
Current Treatment Options in Neurology|April 28, 2015
The transition from first-line to second-line therapy in multiple sclerosisJan Dörr, Friedemann Paul
Drug Design, Development and Therapy|November 2, 2016
Alemtuzumab in the treatment of multiple sclerosis: patient selection and special considerationsJan Dörr, Karl Baum
Degenerative Neurological and Neuromuscular Disease|July 17, 2020
Optimal management of multiple sclerosis during pregnancy: current perspectivesNadja Borisow, Friedemann Paul, Jan Dörr
The EPMA Journal|January 30, 2013
Can we prevent or treat multiple sclerosis by individualised vitamin D supply?Jan Dörr, Andrea Döring, Friedemann Paul
Trials|February 10, 2012
Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trialJan Dörr, Stephanie Ohlraun, Horst Skarabis, et al.
Journal of Alzheimer'S Disease : JAD|March 26, 2014
Update on Susac syndrome: new insights in brain and retinal imaging and treatment optionsJan Dörr, Marius Ringelstein, Thomas Duning, et al.
The EPMA Journal|June 29, 2012
Exercise in multiple sclerosis -- an integral component of disease managementAndrea Döring, Caspar F Pfueller, Friedemann Paul, et al.
Journal of Neuroimmunology|January 5, 2002
Induction of TRAIL-mediated glioma cell death by human T cellsJan Dörr, Sonia Waiczies, Uwe Wendling, et al.
Degenerative Neurological and Neuromuscular Disease|July 17, 2020
Optical coherence tomography for retinal imaging in multiple sclerosisHanna Zimmermann, Timm Oberwahrenbrock, Alexander U Brandt, et al.
Pageof 8